Open mobile menu
Model.SiteSettings!.GetInTouchLink!.Name Contact Us
Jroberts Jruaux Dpingstone 03 B012378 CROPPED
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

VENCLEXTA®

A to Z: Drugs in Highlight: V is for VENCLEXTA®

News A to Z Feature 30/04/2025

Our A to Z series highlights VENCLEXTA® (venetoclax) from AbbVie, a medication used to treat both chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML). This article explores its mechanism of action, clinical applications, and the patent protection surrounding this important drug.

Read more
Untitled Design 2023 04 26T114822.422
Industry news, News 26/04/2023

World Intellectual Property Day: Celebrating the change makers

Newcastle Tyne Bridge [Unsplash]
News, Team news 16/04/2023

Secerna Expands to Newcastle with New City Centre Office

Alarm Clocks April 2023
Industry news, News 11/04/2023

New EPO Guidance on Notification Changes that will Abolish the Ten-Day Rule

Shutterstock 1556606726
Industry news, News 04/04/2023

Intellectual Property Status Quo Preserved as the UK Joins Comprehensive and Progressive Trans-Pacific Partnership

B012753
Events, News 17/03/2023

Secerna to attend BioMedica conference

Conference
Industry news 08/03/2023

Secerna to attend Made Smarter Advanced Manufacturing Technology Showcase in Sunderland

GB1 7522 Holly Image 1
Team news, Careers 07/03/2023

Holly Smith in profile

Wf Alt
Industry news, News 07/03/2023

UK court decision relating to renewable energy technology defines the territorial field of patent law

Tick List
Industry news, News 01/03/2023

Navigating the European Regional Phase (ERP) of your patent application

16 17 18 19 20 21 22 23 24 25 26